Figure 2 : Caspase-3 immunostaining in stable atherosclerotic plaques and in the vascular tissue controls.

(A) fibrous plaque with none caspase-3 immunostaining, neither in the extracellular matrix nor in the cells present here.
(B) early fibro-atheroma without caspase-3 immunostaining in all parts of it. (C) No caspase-3 immunostaining in the vascular
tissuecontrols. (D) Graph. A bar chart representing a comparison of the % caspase-3 positive area of controls (n.20) vs. stable
atherosclerotic plaques (n.58), expressed by % positive, dark brown pixels of the analyzed fields. Data are presented as mean±SD.
p>0,05. A, B and C, original magnification 10x; scale bars:50 μm.

Musumeci et al.Journal of Histology & Histopathology  2014 1:4DOI : 10.7243/2055-091X-1-4